Two Sigma Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.9M | Buy |
6,392,628
+1,877,311
| +42% | +$14.6M | 0.05% | 418 |
|
|
2025
Q4 | $35.2M | Buy |
4,515,317
+95,688
| +2% | +$692K | 0.05% | 469 |
|
|
2025
Q3 | $33.5M | Buy |
4,419,629
+131,406
| +3% | +$1.09M | 0.05% | 446 |
|
|
2025
Q2 | $38.4M | Buy |
4,288,223
+2,242,688
| +110% | +$20.9M | 0.07% | 353 |
|
|
2025
Q1 | $15.3M | Buy |
2,045,535
+271,321
| +15% | +$2.19M | 0.03% | 588 |
|
|
2024
Q4 | $13.3M | Buy |
1,774,214
+13,406
| +0.8% | +$102K | 0.03% | 634 |
|
|
2024
Q3 | $13.4M | Buy |
1,760,808
+86,417
| +5% | +$657K | 0.03% | 636 |
|
|
2024
Q2 | $10.3M | Buy |
1,674,391
+99,750
| +6% | +$550K | 0.02% | 697 |
|
|
2024
Q1 | $8M | Sell |
1,574,641
-777,079
| -33% | -$4.37M | 0.02% | 739 |
|
|
2023
Q4 | $14.1M | Buy |
2,351,720
+595,575
| +34% | +$3.45M | 0.03% | 541 |
|
|
2023
Q3 | $12.4M | Buy |
1,756,145
+424,657
| +32% | +$3.05M | 0.03% | 530 |
|
|
2023
Q2 | $9.37M | Sell |
1,331,488
-8,830
| -0.7% | -$70.9K | 0.03% | 669 |
|
|
2023
Q1 | $11.2M | Buy |
1,340,318
+826,411
| +161% | +$7.96M | 0.03% | 549 |
|
|
2022
Q4 | $5.9M | Sell |
513,907
-517,252
| -50% | -$6.45M | 0.02% | 785 |
|
|
2022
Q3 | $13M | Buy |
1,031,159
+788,618
| +325% | +$10.1M | 0.05% | 418 |
|
|
2022
Q2 | $2.57M | Buy |
242,541
+43,417
| +22% | +$448K | 0.01% | 1055 |
|
|
2022
Q1 | $3.24M | Sell |
199,124
-1,024,065
| -84% | -$16.4M | 0.01% | 1129 |
|
|
2021
Q4 | $16.9M | Sell |
1,223,189
-1,044,456
| -46% | -$13.8M | 0.04% | 548 |
|
|
2021
Q3 | $32.6M | Buy |
2,267,645
+417,160
| +23% | +$6.58M | 0.09% | 300 |
|
|
2021
Q2 | $29.3M | Buy |
1,850,485
+1,792,116
| +3,070% | +$24.3M | 0.08% | 357 |
|
|
2021
Q1 | $594K | Sell |
58,369
-1,015,047
| -95% | -$10.5M | ﹤0.01% | 2771 |
|
|
2020
Q4 | $8M | Sell |
1,073,416
-892,023
| -45% | -$4.6M | 0.03% | 686 |
|
|
2020
Q3 | $6.75M | Sell |
1,965,439
-897,942
| -31% | -$3.85M | 0.03% | 667 |
|
|
2020
Q2 | $13.6M | Buy |
2,863,381
+1,731,860
| +153% | +$6.92M | 0.08% | 304 |
|
|
2020
Q1 | $2.26M | Sell |
1,131,521
-293,934
| -21% | -$809K | 0.02% | 902 |
|
|
2019
Q4 | $4.92M | Buy |
1,425,455
+667,056
| +88% | +$1.68M | 0.02% | 960 |
|
|
2019
Q3 | $2.17M | Buy |
758,399
+192,230
| +34% | +$598K | 0.01% | 1364 |
|
|
2019
Q2 | $2.15M | Buy |
566,169
+292,561
| +107% | +$1.76M | 0.01% | 1401 |
|
|
2019
Q1 | $2.23M | Buy |
273,608
+255,608
| +1,420% | +$2.19M | 0.01% | 1352 |
|
|
2018
Q4 | $145K | Sell |
18,000
-130,649
| -88% | -$1.02M | ﹤0.01% | 2768 |
|
|
2018
Q3 | $1.13M | Buy |
148,649
+6,828
| +5% | +$45.9K | ﹤0.01% | 1886 |
|
|
2018
Q2 | $813K | Buy |
141,821
+88,621
| +167% | +$488K | ﹤0.01% | 2305 |
|
|
2018
Q1 | $254K | Sell |
53,200
-238,228
| -82% | -$1.22M | ﹤0.01% | 2861 |
|
|
2017
Q4 | $1.43M | Buy |
291,428
+186,881
| +179% | +$905K | 0.01% | 1714 |
|
|
2017
Q3 | $548K | Sell |
104,547
-236,466
| -69% | -$1.21M | ﹤0.01% | 2092 |
|
|
2017
Q2 | $1.9M | Sell |
341,013
-116,634
| -25% | -$710K | 0.01% | 1461 |
|
|
2017
Q1 | $3.84M | Buy |
457,647
+417,339
| +1,035% | +$2.9M | 0.01% | 1070 |
|
|
2016
Q4 | $255K | Buy |
+40,308
| New | +$210K | ﹤0.01% | 2828 |
|
|
2014
Q3 | – | Sell |
-257,889
| Closed | -$3.29M | – | 1748 |
|
|
2014
Q2 | $3.29M | Buy |
+257,889
| New | +$2.51M | 0.01% | 849 |
|
|
2014
Q1 | – | Sell |
-37,043
| Closed | -$281K | – | 1983 |
|
|
2013
Q4 | $281K | Sell |
37,043
-87,613
| -70% | -$555K | ﹤0.01% | 1904 |
|
|
2013
Q3 | $908K | Buy |
+124,656
| New | +$632K | 0.01% | 1057 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC